Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Exercise as a Buffer Against Stress-induced Overeating

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02936076
Recruitment Status : Completed
First Posted : October 18, 2016
Results First Posted : October 23, 2019
Last Update Posted : March 29, 2021
Sponsor:
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
The Miriam Hospital

Brief Summary:
The purpose of this study is to examine the psychological benefits of chronic exercise as well as the effects of exercise training on eating behaviors and stress-induced overeating in overweight and obese women. Participants will be randomized to an 12-week exercise condition or a delayed exercise condition. Assessments will occur at baseline, 6 weeks, and 12 weeks and will include answering surveys in real-time using smartphones, several assessments of eating behaviors and dietary intake, and questionnaire measures of factors which could mediate the relationship between exercise and eating. Participants will be compensated for completing assessments and for adherence to the exercise protocol.

Condition or disease Intervention/treatment Phase
Obesity Other: Exercise intervention Other: Delayed exercise intervention Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 49 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Exercise as a Buffer Against Stress-induced Overeating
Actual Study Start Date : January 16, 2017
Actual Primary Completion Date : November 1, 2018
Actual Study Completion Date : May 21, 2019

Arm Intervention/treatment
Active Comparator: Exercise condition
Participants randomized to the exercise condition will participate in a 12-week exercise training program. The exercise intervention will consist of both supervised and unsupervised exercise sessions and progress to 200 minutes/week of moderate-intensity exercise. Exercise bouts will be spread across 4-6 days and be at least 20 minutes in duration. During supervised visits, heart rate will be monitored by a member of the research staff to ensure that exercise is within the prescribed intensity range and ratings of perceived exertion and feeling state will be assessed periodically. Unsupervised exercise will be verified using objective physical activity monitors.
Other: Exercise intervention
Placebo Comparator: Delayed exercise condition
Participants randomized to the delayed exercise condition will be asked not to change their exercise or eating habits over the 12-week period and will complete the same assessment measures as the exercise condition. However, following the completion of the 12-week period, participants will be given two options: 1) receive a one-on-one session with an exercise physiologist at our center and receive a written exercise program, and at this time point all study obligations will be completed, or 2) complete the identical exercise protocol as the 'exercise' condition.
Other: Delayed exercise intervention



Primary Outcome Measures :
  1. Stress-induced Overeating Measured Via Smartphone Surveys [ Time Frame: 12 weeks ]
    Participants completed EMA surveys (5x/day for 14 days). At each prompt they were asked if an eating episode occurred. If they indicated 'yes', they were asked to check all that apply: a) I ate past the point of feeling full, b) I ate more than usual, c) I had unplanned eating (i.e., consumed food when I don't usually eat and was not making up for a missed meal, or d) None of the above. If the participant responded with a, b, or c, it was classified as an 'overeating episode'. Further, at each prompt, participants were asked to the respond to the following: 'Right now I feel stressed' (1=not at all, 7=very much so). If the stress score was >=5 at the prompt just prior to an overeating episode, then it was considered a 'stress-induced overeating episode'.

  2. Percentage of Overeating Episodes Characterized as 'Overeating' [ Time Frame: 12 weeks ]
    If an eating episode occurred, participants were asked to check all that apply: a) I ate past the point of feeling full, b) I ate more than usual, c) I had unplanned eating (i.e., consumed food when I don't usually eat and was not making up for a missed meal, or d) None of the above. If response was a, b, or c, it was classified as an 'overeating episode'.


Secondary Outcome Measures :
  1. Change in Body Weight (% Initial Weight) [ Time Frame: baseline and 12 weeks ]
    Percent weight change from baseline to 12 weeks

  2. Stress as Measured Via Questionnaire [ Time Frame: Baseline and 12 weeks ]
    The 10-item Perceived Stress Scale (Cohen 1988) was used to assess changes in stress by treatment arm from baseline to 12 weeks. Scores on this measure range from 0-40 with a higher score indicating greater perceived stress. Presented values are 12 week scores adjusted for baseline values.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Female
  • 18-60 years of age
  • BMI 25 to <40 kg/m2
  • Physically inactive (<60 min/week of physical activity)
  • Must own a smartphone
  • Must be willing to receive and respond to text message prompts for 14 days at baseline, 6 and 12 weeks

Exclusion Criteria:

  • Shift workers
  • Individuals who do not endorse stress-eating
  • Recent weight loss or current enrollment in a weight loss program
  • Women who are pregnant or plan on becoming pregnant in the next 6 months
  • Any medical condition that would limit participation in physical activity
  • Diabetes
  • Inability to walk without an assisted device
  • Inability to meet exercise recommendations
  • Failure to adequately complete all baseline assessment measures

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02936076


Locations
Layout table for location information
United States, Rhode Island
Weight Control and Diabetes Research Center
Providence, Rhode Island, United States, 002903
Sponsors and Collaborators
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  Study Documents (Full-Text)

Documents provided by The Miriam Hospital:
Study Protocol  [PDF] October 11, 2017
Statistical Analysis Plan  [PDF] September 11, 2019

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: The Miriam Hospital
ClinicalTrials.gov Identifier: NCT02936076    
Other Study ID Numbers: 592916-14
K01DK100498 ( U.S. NIH Grant/Contract )
First Posted: October 18, 2016    Key Record Dates
Results First Posted: October 23, 2019
Last Update Posted: March 29, 2021
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Hyperphagia
Signs and Symptoms, Digestive